English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Hepatoseluler Karsinoma Rekurrensinin Erken Tanisinda P2/MS ve AFP’nin Etkinligi Ozet Amac:  P2/MS basit, ucuz ve not-invaziv bir test olup sirozda karaciger fibrozunu degerlendirmek icin kullanilir. Hepatoseluler karsinomada artmis alfa-fetoprotein duzeyleri rekurrens ile iliskilidir. Bu calismada hepatoseluler karsinoma nuksunun erken donem ongorumunde P2/MS ve alfa-fetoproteinin etkinligi ve P2/MS ve alfa-fetoprotein icin sinir degerler belirlenmesi amaclanmistir. Gerec ve yontem:  Retrospektif olarak 69 hepatoseluler karsinoma hastasi, rekurrens varligi acisindan tarandi. Kanser rekurrensi radyolojik olarak trifazik tomografi ve manyetik rezonans inceleme ile belirlendi. P2/MS formulu icin [trombosit sayisi (10 9 /L)] 2 /[monosit yuzdesi x notrofil yuzdesi]  kullanildi. Bulgular:  Toplam 42 hastanin hepatoseluler karsinoma rekurrensi vardi. Rekurrens ongorumu icin P2/MS sinir degeri ≤59,9 alindiginda %100 ozgulluk ve %95,24 duyarlilik saptandi. Alfa-fetoprotein icin sinir degeri >57,5 alindiginda ise %83,3 ozgulluk ve %92,6 duyarlilik saptandi. Sonuc:  Bu bulgular isiginda, P2/MS ve alfa-fetoprotein hepatoseluler karsinoma rekurrensini ongordurmede guvenilir belirtecler olarak kabul edilebilir. Hepatoseluler karsinoma rekurrensinin erken tahmininde non-invaziv test olarak kullanilabileceklerini oneriyoruz.  Anahtar kelimeler:  P2/MS, AFP, hepatoseluler kanser, rekurrens. Efficacy of P2/MS and AFP in Early Prediction of Hepatocellular Carcinoma Recurrence Abstract:  Objective:  P2/MS is a simple, inexpensive and non-invasive test for the evaluation of hepatic fibrosis in cirrhosis. Elevated alpha-fetoprotein levels in hepatocellular carcinoma is related with recurrence. We aimed to examine the efficacy of P2/MS and alpha-fetoprotein in early prediction of hepatocellular carcinoma recurrence and to determine a cut-off value for P2/MS and alpha-fetoprotein.  Methods:  Sixty nine patients with hepatocellular carcinoma were  retrospectively scanned for recurrence existence. The recurrence of hepatocellular carcinoma was diagnosed radiologically, via 3-phase tomography and magnetic resonance investigation. The formula of P2/MS was platelet count (10 9 /L) 2 /[monocyte count (%) x neutrophil count (%)].  Results:  Forty two patients had hepatocellular carcinoma recurrence. For the recurrence prediction,  the  cut-off value of P2/MS was ≤59.9 with 100% specificity and 95.24% sensitivity. The cut-off value of alpha-fetoprotein was found >57.5 with 83.3% sensitivity and 92.6% specificity.  Conclusion:  With these findings, P2/MS and alpha-fetoprotein seems as  reliable markers for the prediction of hepatocellular carcinoma recurrence. We suggest that they can be used as non-invasive tools for the early estimation of hepatocellular carcinoma recurrence.  Key Words:  P2/MS, AFP, hepatocellular carcinoma, recurrence.